News | December 24, 2021
Indian Pharmaceutical Market grew at 6.6 pc in November
Flattish volume growth and subdued new launches were key factors for last month
Flattish volume growth and subdued new launches were key factors for last month
Contribution from the top five therapies stood at 58% of IPM in October 2021. These therapies are cardiac, anti-infectives, gastro-intestinal, anti-diabetic and vitamins
The nutraceutical sector is on the cusp of exponential growth and Covid-19 has accelerated the pace of its applications. Dr R.B Smarta, CMD, Interlink, shares his perspective on the growth opportunities and challenges for the sector
The consideration for the acquisition is US $ 2.25 million
This funding will help the start-up consolidate its position as a one-stop destination for pet parents as they holistically reimagine the entire pet care ecosystem
A total of 8308 stores are open across India and medicines are priced at affordable rates
The order strengthens the company’s position in the East African market
The focus is on wellness and personal care products
The segment delivered strong sales growth of 20% YoY
The company has predominantly built a portfolio into veterinary products
Subscribe To Our Newsletter & Stay Updated
